Search Results - "Quan, P"

Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis by Nallasamy, Palanisamy, Nimmakayala, Rama Krishna, Karmakar, Saswati, Leon, Frank, Seshacharyulu, Parthasarathy, Lakshmanan, Imayavaramban, Rachagani, Satyanarayana, Mallya, Kavita, Zhang, Chunmeng, Ly, Quan P., Myers, Molly S., Josh, Lindenberger, Grabow, Corinn E., Gautam, Shailendra K., Kumar, Sushil, Lele, Subodh M., Jain, Maneesh, Batra, Surinder K., Ponnusamy, Moorthy P.

“…Tumor-microenvironment factors and cancer stem cells (CSCs) play a critical role in the aggressiveness of pancreatic cancer (PC). However, the degree to which…”
Get full text

Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation by Olson, Madeline T., Ly, Quan P., Mohs, Aaron M.

“…Surgical resection continues to function as the primary treatment option for most solid tumors. However, the detection of cancerous tissue remains…”
Get full text

CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma by Awaji, Mohammad, Saxena, Sugandha, Wu, Lingyun, Prajapati, Dipakkumar R., Purohit, Abhilasha, Varney, Michelle L., Kumar, Sushil, Rachagani, Satyanarayana, Ly, Quan P., Jain, Maneesh, Batra, Surinder K., Singh, Rakesh K.

“…Pancreatic ductal adenocarcinoma (PDAC) remains one of the most challenging malignancies. Desmoplasia and tumor‐supporting inflammation are hallmarks of PDAC…”
Get full text

Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer by Qi, Bowen, Crawford, Ayrianne J., Wojtynek, Nicholas E., Holmes, Megan B., Souchek, Joshua J., Almeida-Porada, Graca, Ly, Quan P., Cohen, Samuel M., Hollingsworth, Michael A., Mohs, Aaron M.

“…Pancreatic ductal adenocarcinoma is highly lethal and surgical resection is the only potential curative treatment for the disease. In this study, hyaluronic…”
Get full text

Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma by Lin, Chi, Verma, Vivek, Ly, Quan P., Lazenby, Audrey, Sasson, Aaron, Schwarz, James K., Meza, Jane L., Are, Chandrakanth, Li, Sicong, Wang, Shuo, Hahn, Stephen M., Grem, Jean L.

“…•No studies have assessed SBRT + NFV for borderline/unresectable pancreatic cancer.•This phase I trial enrolled 46 patients, of which 39 received per-protocol…”
Get full text

Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis by Kaushik, Garima, Seshacharyulu, Parthasarathy, Rauth, Sanchita, Nallasamy, Palanisamy, Rachagani, Satyanarayana, Nimmakayala, Rama Krishna, Vengoji, Raghupathy, Mallya, Kavita, Chirravuri-Venkata, Ramakanth, Singh, Amar B., Foster, Jason M., Ly, Quan P., Smith, Lynette M., Lele, Subodh M., Malafa, Mokenge P., Jain, Maneesh, Ponnusamy, Moorthy P., Batra, Surinder K.

“…Pancreatic cancer (PC) is difficult to defeat due to mechanism (s) driving metastasis and drug resistance. Cancer stemness is a major challenging phenomenon…”
Get full text

Complex Resonant Scattering Behavior in the Surface Plasmon Resonance Imaging Microscopy of Single Gold Nanorods by Fan, Yunshan, Aceta, Yara, Hessong, Esther, Bengston, Athena, Biageyian, Laris A, Huynh, Quan P, Corn, Robert M

“…Diffraction patterns observed in surface plasmon resonance imaging (SPRI) microscopy measurements of single gold nanorods (AuNRs) exhibit a complex behavior at…”
Get full text

Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer by Muilenburg, Kathryn M., Isder, Carly C., Radhakrishnan, Prakash, Batra, Surinder K., Ly, Quan P., Carlson, Mark A., Bouvet, Michael, Hollingsworth, Michael A., Mohs, Aaron M.

“…Pancreatic cancer is difficult to resect due to its unique challenges, often leading to incomplete tumor resections. Fluorescence-guided surgery (FGS), also…”
Get full text

Aerospace competition, investor attention, and stock return comovement by Do, Hung X., Nguyen, Nhut H., Nguyen, Quan M.P., Truong, Cameron

“…·Satellite launches distract investors from the stock market.·Investors focus more on market-level rather than firm-specific shocks on launch days.·This drives…”
Get full text

Single-cell RNA-sequencing of human spleens reveals an IDO-1+ Tolerogenic Dendritic Cell subset in pancreatic cancer patients that is absent in normal individuals by Mundry, Clara S., Triplett, Aleata A., Shah, Osama Shiraz, Chaitankar, Vijender, McAndrews, Kyle L., Ly, Quan P., Cox, Jesse L., Eberle, Kirsten C., Mehla, Kamiya, Swanson, Benjamin J., Lazenby, Audrey, Klute, Kelsey A., Grandgenett, Paul M., Hollingsworth, Michael A.

“…Local and systemic immunosuppression are prominent features of pancreatic cancer, rendering anti-tumor effector cells inactive and immunotherapeutic approaches…”
Get full text

Asymmetric trading responses to credit rating announcements from issuer‐ versus investor‐paid rating agencies by Nguyen, Quan M. P., Do, Hung Xuan, Molchanov, Alexander, Nguyen, Lily, Nguyen, Nhut H.

“…The credit rating industry has traditionally followed the “issuer‐pays” principle. Issuer‐paid credit rating agencies (CRAs) have faced criticism regarding…”
Get full text

A bibliometric analysis of primary ovarian insufficiency from 2010 to 2020 by Deng, Z.-H., Tan, H.-J., Wang, L., Long, P.-P., Guo, D., Quan, R.-P., Zeng, M.-H., Deng, H.-W., Xiao, H.-M.

“…This study aimed to carry out a bibliometric analysis of primary ovarian insufficiency (POI) from 2010 to 2020 and to reveal the research status and hotspots…”
Get full text

Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer by Olson, Madeline T., Aguilar, Eric N., Brooks, Cory L., Isder, Carly C., Muilenburg, Kathryn M., Talmon, Geoffrey A., Ly, Quan P., Carlson, Mark A., Hollingsworth, Michael A., Mohs, Aaron M.

“…Surgery remains the only potentially curative treatment option for pancreatic cancer, but resections are made more difficult by infiltrative disease, proximity…”
Get full text

Metastatic Giant Cell Tumor Causing Small Bowel Intussusception on 18 F-FDG PET/CT by Walcutt, Julie E., Johnson, Craig M., Ly, Quan P., Downey, Ryan T.

“…ABSTRACTAn 89-year-old man with a history of a malignant giant cell tumor of soft parts in the right thigh with recurrent/metastatic tumor in the right pelvis…”
Get full text

Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer by Olson, Madeline T, Wojtynek, Nicholas E, Talmon, Geoffrey A, Caffrey, Thomas C, Radhakrishnan, Prakash, Ly, Quan P, Hollingsworth, Michael A, Mohs, Aaron M

“…Surgical resection is currently the only potentially curative option for patients with pancreatic cancer. However, the 5-year survival rate after resection is…”
Get full text

Abnormal activation of Ras/Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endometrial stromal cells of patients with endometriosis by Yotova, I.Y., Quan, P., Leditznig, N., Beer, U., Wenzl, R., Tschugguel, W.

“…BACKGROUND Enhanced proliferation and survival of eutopic endometrial cells from patients with endometriosis compared with healthy women is associated with…”
Get full text

Electrosynthesized poly(1,5-diaminonaphthalene)/polypyrrole nanowires bilayer as an immunosensor platform for breast cancer biomarker CA 15-3 by Nguyen, Vân-Anh, Nguyen, Huy L., Nguyen, Dzung T., Do, Quan P., Tran, Lam D.

“…In this paper, an electrosynthesized bilayer film of polypyrrole nanowire and poly(1,5diaminonaphthalene) on a disposable screen-printing carbon ink electrode…”
Get full text

Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis by Cole, Kathryn E., Ly, Quan P., Hollingsworth, Michael A., Cox, Jesse L., Padussis, James C., Foster, Jason M., Vargas, Luciano M., Talmadge, James E.

“…•Cancer patient spleen a source of immature myeloid cells.•Higher frequency of MDSCs in cancer patient’s peripheral blood versus their spleen.•Clustering…”
Get full text

Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial by Verma, Vivek, Lazenby, Audrey J, Zheng, Dandan, Bhirud, Abhijeet R, Ly, Quan P, Are, Chandrakanth, Sasson, Aaron R, Lin, Chi

“…Abstract Purpose Prospectively assess relationships between dosimetric parameters and histopathologic/clinical duodenal toxicities in patients on a phase I…”
Get full text

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β by Kaushal, Jyoti, Bhatia, Rakesh, Kanchan, Ranjana, Raut, Pratima, Mallapragada, Surya, Ly, Quan, Batra, Surinder, Rachagani, Satyanarayana

“…Niclosamide (Nic), an FDA-approved anthelmintic drug, is reported to have anti-cancer efficacy and is being assessed in clinical trials for various solid…”
Get full text